Dünya Çapında Bir Halk Sağlığı Problemi Olan Kolorektal Karsinomda Tarama Stratejileri ve Kolonoskopinin Yeri

Kolorektal kanser; çevresel ve genetik faktörlerden etkilenen sık rastlanılan ölümcül bir hastalıktır. Tüm dünyada KRK'ler akciğer ve meme kanserinden sonra en sık gözlenen üçüncü kanser türüdür ve tüm kanser nedenlerine bağlı ölümlerde dördüncü sıradadır. Sıklıkla sanayileşmiş ülkelerde gözlenmekle birlikte, gelişmekte olan ülkelerde de KRK gözlenme sıklığının arttığına dair bildiriler mevcuttur. Bu nedenle KRK'de, uygulanabilir ve bilimsel temellere dayalı tarama programlarının uygulanması hayati öneme haizdir. Tarama yapılmasının KRK'de mortaliteyi azalttığı gösterilmiştir. Kolonoskopi, kolonun incelenmesine ve hastalıklarının tedavisine olanak sağlayan tanısal ve tedavi edici bir tekniktir ve KRK taramasında vazgeçilmez bir köşetaşıdır.

[Screening Strategies In A Global Public Health Issue Colorectal Carcinoma and Place of Colonoscopy]

Colorectal cancer (CRC) is a common and lethal disease which is influenced by both environmental and genetic factors. CRC is the third most common diagnosis of cancer following lung and breast cancers and the fourth leading cause of cancer death. Although commonly seen in high income countries, but there are many reports of increasing trend of this cancer in middle income countries. So, it is crucial to performing adoptable and science based screening strategies in CRC. Screening has been shown to decrease mortality from CRC. Colonoscopy is a both diagnostic and therapeutic technique which permits examination and treatment of colon and also it is an inevitable cornerstone in CRC screening.

PDF

___

1. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380(9856):1840-50.
2. Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012;4(4):68-70.
3. Masoompour Seyed Masoom, Yarmohammadi Hooman, Rezaianzadeh Abbas, Lankarani Kamran Bagheri. Cancer incidence in southern Iran, 1998-2002: Results of population-based cancer registry. Cancer epidemiology.2011;35(5):e42-e47.
4. Torres Udos S, Almeida TE, Netinho JG. Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008. Rev Panam Salud Publica. 2010;28(4):244-8.
5. Beaulieu N, Bloom D, Bloom R, Stein R. Breakaway: The global burden of cancer-- challenges and opportunities.The Economist Intelligence Unit. 2009.
6. Lankarani KB. Why colorectal diseases are important? Ann Colorectal Res: 2013;1(1):in press. DOI: 10.5812/acr.11480.
7. Dunne C, Harewood GC. Hidden extras: the projected impact of colorectal cancer screening and the burden of procedures on screening centers. Gastrointest Endosc. 2011;74(2):448-9.
8. Shellnut JK, Wasvary HJ, Grodsky MB, Boura JA, Priest SG. Evaluating the age distribution of patients with colorectal cancer: are the United States Preventative Services Task Force guidelines for colorectal cancer screening appropriate? Dis Colon Rectum. 2010;53(1):5-8.
9. Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı 2006-2008 yılları Türkiye Kanser İnsidansı, http://www.kanser.gov.tr.
10. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu, Kolorektal Kanser Tarama Programı Ulusal Standartları. http://thsk.gov.tr. 02 Aralık 2012.
11. Zauber AG, Winawer SJ, O'Brien MJ, LansdorpVogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687- 96
12. Ashktorab H, Nouraie M, Hosseinkhah F. A 50- year review of colorectal cancer in African Americans: implications for prevention and treatment. Dig Dis Sci 2009; 54:1985.
13. Edwards BK, Ward E, Kohler BA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544.
14. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010; 138:2029.
15. Couch D, Bullen N, Ward-Booth S, Adams C. What interval between colorectal cancer resection and first surveillance colonoscopy? An audit of practice and yield. Colorectal Dis. 2012 Jul 27 .1463-1318.
16. Baca B, Beart RW Jr, Etzioni DA. Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum. 2011 Aug;54(8):1036-48.
17. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR; United States MultiSociety Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012 Sep;143(3):844-57.
18. Winawer SJ, Zauber AG, Gerdes H. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334:82.
19. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 May-Jun;58(3):130-60.
20. Laurent S, Franchimont D, Coppens JP, Leunen K, Macken L, Peeters M, et al. Familial adenomatous polyposis: clinical presentation, detection and surveillance. Acta Gastroenterol Belg. 2011 Sep;74(3):415-20.
21. Brosens LA, van Hattem WA, Jansen M, de Leng WW, Giardiello FM, Offerhaus GJ. Gastrointestinal polyposis syndromes. Curr Mol Med. 2007 Feb;7(1):29-46.
22. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010 Jun;138(6):2044-58.
23. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010 Jan;8(1):8-61.
24. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009 Mar;104(3):739-50.
25. Parkin DM, Pisani, P, Ferlay, J. Global cancer statistics. CA Cancer J Clin 1999; 49:33. 26. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990; 113:373.
27. Ashktorab H, Nouraie M, Hosseinkhah F. A 50- year review of colorectal cancer in African Americans: implications for prevention and treatment. Dig Dis Sci 2009; 54:1985.
28. Edwards BK, Ward E, Kohler BA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544.
29. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010; 138:2029.
30. Standards Committee, American Society of Colon and Rectal Surgeons- Practice parameters for the detection of colorectal neoplasms, 1999.
31. Brown SR, Baraza W.Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum Cochrane Database Syst Rev. 2010 Oct 6;(10): CD006439. doi: 10.1002/14651858. CD006439.pub3.Bond JH. Colon polyps and cancer. Endoscopy. 2003;35:27-35.
32. Kudo S, Tamura S, Nakajıma T et al. Diagnosis of colorectal tumorous lesions by magnif ying endoscopy. Gastrointest Endosc 1996; 44: 8-14.
33. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191.
34. Yoshida M, Tsukamoto Y, Niwa Y et al. - Endoscopic assessment of invasion of colorectal tumors with a new highfrequency ultrasound probe. Gastrointest Endosc 1995; 587-92.